Inventors:
Burton Dickey - Houston TX, US
Michael Tuvim - Houston TX, US
Scott Evans - Houston TX, US
International Classification:
A61K 38/08, A61P 31/12, A61P 31/04, A61P 37/04, A61P 31/22, A61P 31/16, A61P 31/14, A61P 31/20, A61P 31/00, A61P 31/10
Abstract:
Embodiments of the invention are directed to methods of treating, inhibiting or attenuating a microbial infection in an individual who has or is at risk for developing such an infection, comprising the step of administering an effective amount of a TLR9 agonist and a TLR 2/6 agonist to the individual.